AG-120, an Oral, Selective, First-in-Class, Potent Inhibitor of Mutant IDH1, Reduces Intracellular 2HG and Induces Cellular Differentiation in TF-1 R132H Cells and Primary Human IDH1 Mutant AML Patient Samples Treated Ex VivoErica Hansen, Katharine Yen, Cyril Quivoron et al.|Blood|2014Cited by 49
IDH1 Mutant Inhibitor Induces Cellular Differentiation and Offers a Combination Benefit With Ara-C In a Primary Human Idh1 Mutant AML Xenograft ModelKatharine Yen, Fang Wang, Hua Yang et al.|Blood|2013Cited by 13